Blood test kit

• US 7,824,873 B2
• Filed: 10/24/2008
• Issued: 11/02/2010
• Est. Priority Date: 03/31/2006
• Status: Expired due to Fees

• Current Assignee: Anne S. Hale
• Original Assignee: Anne S. Hale
• Inventors: Hale, Anne S.
• Primary Examiner(s): Chin; Christopher L
• Application Number:
  US12/257,895
• Publication Number:
  US 20090053830A1
• Time in Patent Office: 739 Days
• Field of Search: None
• US Class Current: 435/7.24
• CPC Class Codes: G01N 33/5094 for blood cell populations red blood cells G01N33/80
• CPC Class Codes: G01N 33/528 Atypical element structures, e.g. gloves, rods, tampons, toilet paper
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing
• CPC Class Codes: G01N 33/80 involving blood groups or blood types or red blood cells white blood cells G01N33/56972
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 436/81 Tube, bottle, or dipstick

Abstract

A blood crossmatching apparatus, kit and methods for testing the compatibility of mammals for blood transfusion. Particulate layers in the apparatus allow nonagglutinated red blood cells to permeate through, while agglutinated red blood cells cannot. The apparatus also has a density solution. The density solution separates white blood cells from red blood cells in the whole blood when centrifuged, without lysing the red blood cells. Thus, the apparatus can be used to test whole blood.

Claims

1. A blood crossmatching apparatus for testing compatibility of mammals for blood transfusion using whole blood comprising:

(a) a centrifugeable tube having an open top end and an opposed closed bottom end;

(b) a first layer comprising particulates at the bottom end in the centrifugeable tube having a permeability enabling nonagglutinated red blood cells of compatible mammals to pass through the layer;

(c) a second layer comprising a density solution layered into the centrifugeable tube over the first layer, wherein the density solution separates white blood cells from red blood cells in the whole blood when centrifuged; and

(d) a third layer layered upon the second layer comprising an immunoglobulin ligand in aqueous solution for bridging weakly agglutinating red blood cells, such that the apparatus can show an incompatibility of the mammals for blood transfusion as a red blood cell band on or in an upper portion of the first layer.

2. A method for testing the compatibility of donor and recipient mammals prior to blood transfusion comprising the steps of:

(a) providing a blood crossmatching apparatus for testing compatibility of mammals for blood transfusion using whole blood comprising a centrifugeable tube having an open top end and an opposed closed bottom end;

a first layer of particulates at the bottom end in the centrifugeable tube having a permeability enabling nonagglutinated red blood cells of compatible mammals to pass through the layer;

a second layer of particulates layered upon the first layer in the centrifugeable tube, wherein particulates of the second layer comprise an immunoglobulin ligand bound to the particulates for bridging weakly agglutinating red blood cells; and

a density solution layered into the centrifugeable tube over the second layer, wherein the density solution separates white blood cells from red blood cells in the whole blood when centrifuged;

(b) dispensing a mixture of the whole donor mammal blood and serum from the recipient mammal into the open top end of the centrifugeable tube of the crossmatching apparatus;

(c) centrifuging the blood crossmatching apparatus to provide a red blood cell band; and

(d) interpreting from a location of the red blood cell band above or below the first layer of particulates in the centrifugeable tube the compatibility of the mammals for blood transfusion.

3. The method of claim 2 wherein the blood crossmatching apparatus is centrifuged at a centrifugal force of between about 500 xg to 700 xg.

4. A method of testing the compatibility of donor and recipient mammals prior to blood transfusion comprising:

(a) collecting whole blood from the donor and serum from the recipient;

(b) diluting the whole blood from the donor;

(c) providing a positive control solution and a negative control solution;

(d) mixing an aliquot of the diluted whole blood from the donor with the serum from the recipient to provide a sample;

(e) mixing an aliquot of the diluted whole blood from the donor with a positive control solution to provide a positive control mixture;

(f) mixing an aliquot of the diluted whole blood from the donor with a negative control solution to provide a negative control mixture;

(g) providing three blood crossmatching apparatuses, each apparatus comprising a centrifugeable tube having an open top end and an opposed closed bottom end;

a first layer of particulates at the bottom end in the centrifugeable tube having a permeability enabling nonagglutinated red blood cells of compatible mammals to pass through the layer;

a second layer of particulates layered upon the first layer in the centrifugeable tube, wherein particulates of the second layer comprise an immunoglobulin ligand bound to the particulates for bridging weakly agglutinating red blood cells; and

a density solution layered into the centrifugeable tube over the second layer, wherein the density solution separates white blood cells from red blood cells in the whole blood when centrifuged;

(h) dispensing an aliquot of the sample into the open top end of a first of the three blood crossmatching apparatuses to provide a sample test apparatus;

(i) dispensing an aliquot of the positive control mixture into the open top end of a second of the three blood crossmatching apparatuses to provide a positive control test apparatus;

(j) dispensing an aliquot of the negative control mixture into the open top end of a third of the three blood crossmatching apparatuses to provide a negative control test apparatus;

(k) centrifuging the three blood crossmatching apparatuses to provide red blood cell bands for each of the test apparatuses;

(l) interpreting the red blood cell bands of the negative control test apparatus and the positive control test apparatus to determine whether the method was properly performed; and

(m) interpreting from a location of the red blood cell band of the sample test apparatus in the centrifugeable tube the compatibility of the mammals for blood transfusion.

5. The method of claim 4, wherein the blood crossmatching apparatus is centrifuged at a centrifugal force of about 500 xg to 700 xg.

6. A blood crossmatching test kit for testing compatibility of mammals for blood transfusion using whole donor blood comprising:

(a) a blood crossmatching apparatus comprising a centrifugeable tube having an open top end and an opposed closed bottom end;

a first layer of particulates at the bottom end in the centrifugeable tube having a permeability enabling nonagglutinated red blood cells of compatible mammals to pass through the layer;

a second layer of particulates layered upon the first layer in the centrifugeable tube, wherein particulates of the second layer comprise an immunoglobulin ligand bound to the particulates for bridging weakly agglutinating red blood cells; and

a density solution layered into the centrifugeable tube over the second layer, wherein the density solution separates white blood cells from red blood cells in the whole blood when centrifuged;

(b) a positive control solution that can agglutinate the blood of any species of mammal used for testing; and

(c) a negative control solution that cannot agglutinate the blood of any species of mammal used for testing.

7. The blood crossmatching test kit of claim 6 further comprising one or more whole blood dilution tubes having a premeasured volume of low ionic strength saline (LISS) for diluting the whole donor blood.

8. The blood crossmatching test kit of claim 6 further comprising one or more reaction tubes for mixing the donor blood and serum of a recipient.

9. The blood crossmatching test kit of claim 6 further comprising one or more disposable pipets capable of dispensing drops having a 50 μ

L volume.

10. The blood crossmatching test kit of claim 6, wherein the centrifugeable tube is a microcentrifuge tube or a micro-hematocrit capillary tube.

11. The blood crossmatching test kit of claim 10, wherein the microcentrifuge tube is a 2 mL or a 1.5 mL microcentrifuge tube.

12. The blood crossmatching test kit of claim 6, wherein the first layer of particulates comprise 6% agarose particles.

13. The blood crossmatching test kit of claim 6, wherein the second layer of particulates comprise 250 micron (μ

m) acrylic beads.

14. The blood crossmatching test kit of claim 6, wherein the density solution comprises an aqueous glycerol solution.

15. The blood crossmatching test kit of claim 14, wherein the aqueous glycerol solution comprises a 97% v/v glycerol solution.

16. The blood crossmatching test kit of claim 6, wherein the immunoglobulin ligand is Protein A.